The RELENT Project
The RELENT Project
The RELENT Project

Facts about RELENT

RELapses prevENTion in chronic autoimmune disease: common mechanisms and co-morbidities (RELENT, grant agreement no. 668036) is a multidisciplinary group of nine scientific partners and four SMEs from Europe, and Australia funded by the European Union’s Horizon 2020 research and innovation programme.

  • The overall aim of RELENT is to develop individualised treatments for autoimmune diseases
  • RELENT has undefined13 partners, from six European countries and one from Australia
  • Nearly 6 Million Euros in project funding provided by the European Commission (H2020)
  • RELENT is coordinated by undefinedRenate Kain from the Medical University Vienna
  • 4.5 years of funding for the project started on 1/11/2015

The RELENT Consortium

RELENT partners

News Section

The understanding of AAV pathogenesis isincreasing, leading to improvements in... Read more

Social Media